CRYOPORT, INC. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
CRYOPORT, INC. (CYRX) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $28.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $28.59M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $22.81M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $45.66M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $46.63M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2026-06-30 | $28.59M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $22.81M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $45.66M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $46.63M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $55.29M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $72.20M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $52.24M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $56.44M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $111.72M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $102.37M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $101.25M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $124.44M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $125.43M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $142.19M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $129.57M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $100.28M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $77.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $37.95M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $39.08M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $42.09M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $75.08M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $41.03M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $14.08K 10-Q · filed 2021-11-04 | $14.08M 10-K · filed 2021-03-01 |
| 2020-09-30 | $14.12M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $134.13M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $12.09M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $12.04M 10-K · filed 2021-03-01 | $12.04M 10-K · filed 2020-03-10 |
| 2019-09-30 | $10.98M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $9.93M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.41M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $5.91M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $5.95M 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |